The Completeness of Reporting (CORE) index identifies important deficiencies in observational study conference abstracts

Journal of Clinical Epidemiology

Volumn 61, Issue 12, 2008, Pages

  Kho, Michelle E ^a   Eva, Kevin W ^a   Cook, Deborah J ^a   Brouwers, Melissa C ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RITUXIMAB;

ARTICLE; CANCER CHEMOTHERAPY; HUMAN; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; RANDOM SAMPLE;

EID: 55249108479     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2008.01.007     Document Type: Article

References (36)

1. Bhandari M., Devereaux P.J., Guyatt G.H., Cook D.J., Swiontkowski M.F., Sprague S., et al. An observational study of orthopaedic abstracts and subsequent full-text publications. J Bone Joint Surg Am 84-A (2002) 615-621
2. Patten M. N.S. rejects funding for cancer drug Avastin but approves others. The Globe and mail (2007 July 14)
3. Patten M. Personal Communications.
4. In: Guyatt G.H., and Rennie D. (Eds). Users' guides to the medical literature: a manual for evidence-based clinical practice (2002), AMA Press, Chicago, IL
5. Devereaux P.J., Choi P.T., El-Dika S., Bhandari M., Montori V.M., Schunemann H.J., et al. An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods. J Clin Epidemiol 57 (2004) 1232-1236
6. Soares H.P., Daniels S., Kumar A., Clarke M., Scott C., Swann S., et al. Bad reporting does not mean bad methods for randomised trials: observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group. BMJ 328 7430 (2004) 22-24
7. Krzyzanowska M.K., Pintilie M., Brezden-Masley C., Dent R., and Tannock I.F. Quality of abstracts describing randomized trials in the proceedings of American Society of Clinical Oncology meetings: guidelines for improved reporting. J Clin Oncol 22 (2004) 1993-1999
8. Hopewell S., and Clarke M. Abstracts presented at the American Society of Clinical Oncology conference: how completely are trials reported?. Clin Trials 2 (2005) 265-268
9. Moher D., Schulz K.F., and Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 285 (2001) 1987-1991
10. von Elm E., Altman D.G., Egger M., Pocock S.J., Gotzsche P.C., and Vandenbroucke J.P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 147 (2007) 573-577
11. Haynes R.B. More informative abstracts: current status and evaluation. J Clin Epidemiol 46 (1993) 595-597 discussion 9
12. Haynes R.B., Mulrow C.D., Huth E.J., Altman D.G., and Gardner M.J. More informative abstracts revisited. Ann Intern Med 113 (1990) 69-76
13. Burns K.E., Adhikari N.K., Kho M., Meade M.O., Patel R.V., Sinuff T., et al. Abstract reporting in randomized clinical trials of acute lung injury: an audit and assessment of a quality of reporting score. Crit Care Med 33 (2005) 1937-1945
14. Friedberg J.W., Kho M.E., Lepisto E.M., Rodriguez M.A., terVeer A., LaCasce A.S., et al. Newly diagnosed follicular (FL), mantle cell (MCL), and diffuse large B cell (DLCL) non-Hodgkin's lymphoma (NHL) in 5 United States comprehensive cancer centers: An analysis from the National Comprehensive Cancer Network (NCCN) NHL Outcomes Project. Blood 304 (2004) 391A
15. Cancer Care Ontario drug formulary-Rituximab. Available at (2005). www.cancercare.on.ca/pdfchemo/rituximab-NHLlo.pdf Accessed November 21, 2007
16. A proposal for more informative abstracts of clinical articles. Ad Hoc Working Group for Critical Appraisal of the Medical Literature. Ann Intern Med 106 (1987) 598-604
17. Hopewell S., Clarke M., and Askie L. Reporting of trials presented in conference abstracts needs to be improved. J Clin Epidemiol 59 (2006) 681-684
18. Mallen C., Peat G., and Croft P. Quality assessment of observational studies is not commonplace in systematic reviews. J Clin Epidemiol 59 (2006) 765-769
19. Narine L., Yee D.S., Einarson T.R., and Ilersich A.L. Quality of abstracts of original research articles in CMAJ in 1989. CMAJ 144 (1991) 449-453
20. Pocock S.J., Collier T.J., Dandreo K.J., de Stavola B.L., Goldman M.B., Kalish L.A., et al. Issues in the reporting of epidemiological studies: a survey of recent practice. BMJ 329 7471 (2004) 883
21. Slim K., Nini E., Forestier D., Kwiatkowski F., Panis Y., and Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 73 (2003) 712-716
22. Tooth L., Ware R., Bain C., Purdie D.M., and Dobson A. Quality of reporting of observational longitudinal research. Am J Epidemiol 161 (2005) 280-288
23. STROBE: STrengthening the Reporting of OBservational studies in Epidemiology. Available at. http://www.strobe-statement.org/ Accessed Sept. 15, 2006
24. Squires B.P. Structured abstracts of original research and review articles. CMAJ 143 (1990) 619-622
25. Juniper E.F., Guyatt G.H., Streiner D.L., and King D.R. Clinical impact versus factor analysis for quality of life questionnaire construction. J Clin Epidemiol 50 (1997) 233-238
26. Streiner D.L., and Norman G.R. Health measurement scales: a practical guide to their development and use. 3rd edition (2003), Oxford University Press
27. Charter R.A., and Larsen B.S. Fisher Z-to-R. Educ Psychol Meas 43 (1983) 41-42
28. Landis J.R., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159-174
29. Kane R.L., Wang J., and Garrard J. Reporting in randomized clinical trials improved after adoption of the CONSORT statement. J Clin Epidemiol 60 (2007) 241-249
30. Moher D., Jones A., and Lepage L. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA 285 (2001) 1992-1995
31. Herbison P. The reporting quality of abstracts of randomised controlled trials submitted to the ICS meeting in Heidelberg. Neurourol Urodyn 24 (2005) 21-24
32. Krzyzanowska M.K., Pintilie M., and Tannock I.F. Factors associated with failure to publish large randomized trials presented at an oncology meeting. JAMA 290 (2003) 495-501
33. Toma M., McAlister F.A., Bialy L., Adams D., Vandermeer B., and Armstrong P.W. Transition from meeting abstract to full-length journal article for randomized controlled trials. JAMA 295 (2006) 1281-1287
34. Scherer R.W., Langenberg P., and von Elm E. Full publication of results initially presented in abstracts. Cochrane Database Syst Rev 2 (2007) MR000005
35. Egger M., and Smith G.D. Bias in location and selection of studies. BMJ 316 7124 (1998) 61-66
36. Cook D.J., Guyatt G.H., Ryan G., Clifton J., Buckingham L., Willan A., et al. Should unpublished data be included in meta-analyses? Current convictions and controversies. JAMA 269 (1993) 2749-2753